BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26298201)

  • 1. Complex I dysfunction underlies the glycolytic switch in pulmonary hypertensive smooth muscle cells.
    Rafikov R; Sun X; Rafikova O; Louise Meadows M; Desai AA; Khalpey Z; Yuan JX; Fineman JR; Black SM
    Redox Biol; 2015 Dec; 6():278-286. PubMed ID: 26298201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to the development of pulmonary arterial hypertension.
    Guo D; Gu J; Jiang H; Ahmed A; Zhang Z; Gu Y
    J Mol Cell Cardiol; 2016 Feb; 91():179-87. PubMed ID: 26774701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
    Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Mutation in the
    James J; Zemskova M; Eccles CA; Varghese MV; Niihori M; Barker NK; Luo M; Mandarino LJ; Langlais PR; Rafikova O; Rafikov R
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):734-754. PubMed ID: 33297749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial hyperfusion induces metabolic remodeling in lung endothelial cells by modifying the activities of electron transport chain complexes I and III.
    Yegambaram M; Sun X; Lu Q; Jin Y; Ornatowski W; Soto J; Aggarwal S; Wang T; Tieu K; Gu H; Fineman JR; Black SM
    Free Radic Biol Med; 2024 Jan; 210():183-194. PubMed ID: 37979892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
    Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
    Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling.
    Tian X; Vroom C; Ghofrani HA; Weissmann N; Bieniek E; Grimminger F; Seeger W; Schermuly RT; Pullamsetti SS
    PLoS One; 2011 Apr; 6(4):e18136. PubMed ID: 21494592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granzyme B deficiency promotes osteoblastic differentiation and calcification of vascular smooth muscle cells in hypoxic pulmonary hypertension.
    Mao M; Zhang M; Ge A; Ge X; Gu R; Zhang C; Fu Y; Gao J; Wang X; Liu Y; Zhu D
    Cell Death Dis; 2018 Feb; 9(2):221. PubMed ID: 29445095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of electron transport chain activity in the embryonic heart coincides with the activation of mitochondrial complex 1 and the formation of supercomplexes.
    Beutner G; Eliseev RA; Porter GA
    PLoS One; 2014; 9(11):e113330. PubMed ID: 25427064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling.
    Veit F; Pak O; Egemnazarov B; Roth M; Kosanovic D; Seimetz M; Sommer N; Ghofrani HA; Seeger W; Grimminger F; Brandes RP; Schermuly RT; Weissmann N
    Antioxid Redox Signal; 2013 Dec; 19(18):2213-31. PubMed ID: 23706097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent inhibition of mitochondrial complex III induces chronic pulmonary vasoconstriction and glycolytic switch in the rat lung.
    Rafikova O; Srivastava A; Desai AA; Rafikov R; Tofovic SP
    Respir Res; 2018 Apr; 19(1):69. PubMed ID: 29685148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
    Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
    Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the phosphatidylinositol 3-kinase/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation.
    Wang G; Ma N; Meng L; Wei Y; Gui J
    Mol Cell Biochem; 2015 Dec; 410(1-2):207-13. PubMed ID: 26350566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.
    Zhuan B; Wang X; Wang MD; Li ZC; Yuan Q; Xie J; Yang Z
    Aging (Albany NY); 2020 Nov; 12(23):23684-23697. PubMed ID: 33221740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperoxia decreases glycolytic capacity, glycolytic reserve and oxidative phosphorylation in MLE-12 cells and inhibits complex I and II function, but not complex IV in isolated mouse lung mitochondria.
    Das KC
    PLoS One; 2013; 8(9):e73358. PubMed ID: 24023862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.
    Barman SA; Chen F; Su Y; Dimitropoulou C; Wang Y; Catravas JD; Han W; Orfi L; Szantai-Kis C; Keri G; Szabadkai I; Barabutis N; Rafikova O; Rafikov R; Black SM; Jonigk D; Giannis A; Asmis R; Stepp DW; Ramesh G; Fulton DJ
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1704-15. PubMed ID: 24947524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.